CoreAge Rx vs Goldspan Health

The verdict

CoreAge Rx edges out Goldspan Health on the Editors' Rating, 94 to 32 (A vs C). Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.

Goldspan Health is still a genuine option — two things shape this listing more than the sticker does. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product instead links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each paired with B12. That storefront then advertises the price as monthly while stating that a new supply arrives automatically every four weeks, which means thirteen charges a year rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than a monthly reading implies. Both figures were already at the higher end of the compounded market before that adjustment. The credit side is real enough: a longevity platform spanning eleven protocol categories, medication dispensed through licensed 503A and 503B pharmacies, and a flat price at any dose. The fifty-state claim on the homepage is qualified by the terms, which say some therapies are unavailable in some states. Weigh the six factors below against your own priorities.